CS Paper Radar

SideAge-RiskNet: Predicted Mammographic-Age Features for Future Breast Cancer Risk and Laterality Prediction

Haoyan Ding, Encheng Su, Chaowei Wu, Lixia Wang, Qian Wang, Garima Diwan, Linda Azab, Yibin Xie, Debiao Li

eess.IV ·submitted 2026-11-04 21:34 UTC · v1

Abstract

Whether breast-specific mammographic aging provides information beyond chronological age for future cancer prediction remains unclear. We propose SideAge-RiskNet, a framework integrating predicted mammographic-age features with breast-specific representations for multi-year breast cancer risk and conditional laterality prediction. A side-aware DenseNet121 trained on never-cancer reference examinations estimates left and right breast ages. Age-adjusted residuals and bilateral age descriptors are subsequently fused with corresponding image representations, while clinical variables contribute through an image--clinical risk branch. The framework jointly predicts cumulative cancer risk over 1--5 years and the subsequently affected breast among unilateral cancer cases. Across 4,480 EMBED and 248 external examinations, pre-cancer scans demonstrated pronounced bilateral age asymmetry. SideAge-RiskNet established state-of-the-art performance in 1--5-year risk assessment over Mirai and AsymMirai with mean risk AUROCs of 81.73% on EMBED and 72.83% on CSMC. Furthermore, it enabled conditional cancer laterality prediction, achieving AUROCs of 73.26% and 82.53%, respectively. This demonstrates the critical utility of bilateral aging phenotypes in localized breast cancer risk surveillance.

Comment
5 pages, 2 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Explicitly Aligned Multi-View Breast Cancer Risk Prediction from Variable-Length Screening Histories

cs.CV cs.AI ·2026-10-12 ·Solveig Thrun, Zijun Sun, Suaiba A. Salahuddin, Kristoffer Wickstrøm, Elisabeth Wetzer +3 more
benchmarkcode/data similarity 0.74
Abstract

Accurate breast cancer risk prediction from screening mammography is essential for improved risk stratification and personalized screening. It can benefit from both temporal breast tissue changes across longitudinal examinations and complementary anatomical information from craniocaudal (CC) and mediolateral oblique (MLO) views. Leveraging longitudinal information requires identifying corresponding tissue regions across examinations, yet most approaches rely on implicit feature alignment without explicitly enforcing spatial consistency. Recent work has demonstrated the benefits of explicit temporal alignment; however, existing methods model each view independently, preventing them from exploiting complementary CC and MLO information. Furthermore, explicit approaches have been limited to a single prior examination. To fill these gaps, we propose (github.com/sot176/FlexLMV-Net), a breast-wise longitudinal multi-view framework that jointly models CC and MLO views across screening examinations while accommodating a variable number of prior examinations. FlexLMV-Net explicitly aligns longitudinal feature maps and integrates complementary views through cross-view temporal fusion and a dual-stream attention block. Evaluated on EMBED and CSAW-CC, FlexLMV-Net consistently outperforms existing approaches across breast density, cancer subtypes, and demographic subgroups, highlighting the benefits of explicit longitudinal alignment, multi-view modeling, and flexible use of available screening history. We further introduce (github.com/sot176/BCRBench), an open-source benchmark that unifies state-of-the-art single- and multi-timepoint breast cancer risk prediction models under standardized preprocessing, training, inference, and evaluation protocols, enabling fair and reproducible comparison of existing methods.

0.25

Beyond AUC: Do Mammography Risk Models Predict When Cancer Occurs?

cs.CV q-bio.QMeess.IV ·2026-11-15 ·Svetlana Krasnova, Andrey Krylov, Dmitry Sorokin
similarity 0.70
Abstract · 7 pages, 2 figures, 1 table. Submitted to ISBI 2027

Longitudinal deep learning models for mammography-based breast cancer risk prediction output either per-year cumulative risks or a discrete distribution over the year of diagnosis, from which cumulative risks F1,...,F5 are derived. These models are evaluated almost exclusively with year-wise AUCs and the concordance index. We show that these metrics are largely insensitive to when cancer occurs: they can be high even for a model that carries no information about the year of diagnosis. We re-evaluate two recent longitudinal models (OA-BreaCR, LMV-Net) on CSAW-CC with a 5-year horizon using timing metrics computed on cancer cases only. Despite C-indices up to 0.75, neither orders cancer cases by time to diagnosis significantly better than chance (c_time 0.51 and 0.55, both 95% CIs covering 0.5). Weighted absolute timing error favours a constant "year 3" prediction over both models, so we use c_time as the primary timing metric. For Mirai's additive-hazard head, also used by LMV-Net, we analyse how per-year increments passed through a ReLU can collapse under severe class imbalance. We also propose a breast-level, two-stage model that separates whether from when. It matches LMV-Net in discrimination (C-index 0.745 vs. 0.746) but orders cancer cases better (c_time 0.58 vs. 0.51, paired 95% CI of the difference 0.01-0.13), on par with Mirai's published weights (0.57).

0.21

Mammo-LIFE: Longitudinal Mammographic Imaging and Clinical Feature Enrichment for Post-Radiotherapy Outcome Prediction

cs.CV eess.IV ·2026-09-22 ·Farnoush Bayatmakou, Maryam Hosseini, Reza Taleei, Arash Mohammadi
similarity 0.69
Abstract

Recent advances in Artificial Intelligence (AI)-powered Computer-Aided Diagnosis (CAD) systems have substantially improved breast cancer screening, diagnosis, and prognosis. Comparatively, postradiotherapy outcome prediction using paired longitudinal mammograms has received considerably less attention. This is largely due to the limited availability of well-annotated longitudinal datasets. Longitudinal mammograms, coupled with paired pre- and post-treatment information, provide a unique opportunity to characterize treatment-induced breast tissue changes following radiotherapy. The resulting learned representations can serve as a valuable asset for advancing personalized radiotherapy planning and post-treatment management. In this context, we propose Mammo-LIFE, a patient-level multimodal framework for post-radiotherapy outcome prediction that combines longitudinal mammographic features with patient-level clinical variables. The imaging branch processes paired pre- and post-treatment mammograms acquired from the four standard views using a mammography-specific encoder adapted via Low-Rank Adaptation (LoRA). Within each view, preand post-treatment representations are explicitly compared through a longitudinal comparison module to capture treatment-related changes. The resulting view-level embeddings are then aggregated using learned view-attention pooling to form a unified patient-level mammographic representation. Selected clinical variables are subsequently combined with the image-derived prediction probability through a late-fusion strategy. To evaluate the effectiveness of combining paired longitudinal mammograms with clinical information, experiments were conducted on an in-house clinical cohort using patient-level stratified five-fold cross-validation.

0.26

Mammography Foundation Models for Opportunistic Prediction of Major Adverse Cardiovascular Events

eess.IV cs.CVcs.LG ·2026-09-16 ·Paula Feldman, Nusrat Binta Nizam, Sunwoo Kwak, Batuhan Karaman, Katerina Dodelzon +1 more
code/data similarity 0.66
Abstract

Cardiovascular disease (CVD) remains the leading cause of death among women, yet cardiovascular risk assessment often relies on clinical variables that may be missing, outdated, or unavailable in routine care. Screening mammography offers an opportunity for opportunistic cardiovascular risk stratification because it is routinely acquired and contains vascular features, including breast arterial calcifications (BAC), that are associated with cardiovascular risk and events. We evaluate whether mammography specific foundation models, originally pretrained for breast cancer-related tasks, can transfer to cardiovascular risk prediction without cardiovascular specific supervision or explicit BAC annotation. We constructed a 5-year major adverse cardiovascular event (MACE) cohort of 22,497 women linked to electronic health record outcomes, including 500 events (2.22% prevalence). The foundation models achieved AUROCs of 0.823 and 0.822 substantially exceeding an age-only model (AUROC 0.765), despite using only the screening mammogram as input, with no clinical variables. Both foundation models evaluated assigned substantially higher predicted risk to patients with radiologist-documented BAC, despite BAC never being used as a training label, and showed activation patterns consistent with vascular findings. Together, these findings suggest that mammography foundation models can recover clinically relevant cardiovascular risk information directly from mammographic pixels and suggest that screening mammography may provide an opportunistic source of cardiovascular risk information to complement conventional clinical assessment without additional imaging. Code is available in https://github.com/PauFeld/MammoCVD

0.36

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.65
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

A Concept-informed Interpretable Artificial Intelligence Framework for Breast Ultrasound Diagnosis

cs.CV ·2026-10-12 ·Shengzhou Zhong, Ziying Wang, Liang Li, Lihua Yan, Shuochun Chen +12 more
code/data similarity 0.65
Abstract · 31 pages, 17 figures, 4 tables

Most existing artificial intelligence systems for breast ultrasound rely primarily on image-driven prediction, with limited incorporation of the knowledge from the Breast Imaging Reporting and Data System (BI-RADS) and the intermediate assessment processes underlying radiologists' workflow, thereby constraining their interpretability and alignment with clinical practice. We curated, to our knowledge, the largest multicenter collection of breast ultrasound images paired with structured BI-RADS descriptors, comprising 9,941 patients across 20 independent datasets. Across 14 testing datasets, IBUS demonstrated consistent generalization performance across different clinical centers and imaging conditions. Incorporating BI-RADS descriptors enabled fine-grained risk stratification, while cross-checking predicted BI-RADS grades against malignancy probabilities identified internally discordant predictions that may warrant additional clinical review. In a reader study involving eight radiologists, IBUS assistance increased diagnostic sensitivity among both junior and senior readers, with the potential of guiding radiologists to make targeted revision in risk stratification. Overall, IBUS exhibits its potential as a second-stage decision-support system that complements radiologists by providing additional risk estimates and interpretable evidence for diagnostically challenging cases. The demo video of IBUS platform is publicly available at https://github.com/zsz1997/IBUS.

0.30

Foundation model embeddings capture pre-diagnostic changes on screening mammograms

cs.CV cs.LG ·2026-09-22 ·Kalina P. Slavkova, Eric Brattain, Aditya Gowd, Akash Pattnaik, Jean-Benoit Delbrouck +4 more
similarity 0.65
Abstract · 13 pages, 5 figures, supplementary info attached

Foundation model embeddings of screening mammograms may encode pre-diagnostic tissue change without task-specific adaptation. We tested whether embeddings move faster along a data-derived "cancer direction" in women later biopsied for cancer than in matched screen-negative controls, and whether this depends on pretraining domain. We studied 1,773 biopsied women (785 malignant, 988 biopsy-negative) and 1,773 matched controls, each with at least two annual screening exams before their index exam. An identical pipeline was applied to four 2D models: Mammo-CLIP (MC, out-of-distribution mammography), HOPPR (in-distribution mammography), MedImageInsight (MII, general medical imaging), and BiomedCLIP (biomedical vision-language pretraining on literature figures). Breast-level embeddings quantified longitudinal movement along the cancer direction. We compared cases and controls using a between-patient design with complementary mixed-effects analysis, and biopsied versus healthy contralateral breasts within patients. Under matched modality in MII embedding space, malignant cases drifted significantly faster than controls in the first two screening intervals preceding the index exam; biopsy-negative cases showed significance only in the first. MC differences were significant in the first interval for both biopsy groups. Within-patient comparisons showed a broadly similar pattern, with MC significance extending to the second interval in both groups and HOPPR showing significance at interval 1. BiomedCLIP showed no significant differences in either design or biopsy group. Overall, directional embedding velocity emerges as a property of clinically grounded rather than general biomedical pretraining, showing that foundation model embeddings can encode pre-diagnostic mammographic change without task-specific adaptation.

0.37

Neoadjuvant chemotherapy response prediction using pretreatment diffusion and contrast-enhanced magnetic resonance imaging with clinical variables

cs.AI cs.CV ·2026-08-18 ·Pablo García Marcos, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez, Covadonga del Camino +4 more
similarity 0.64
Abstract

Prediction of pathological complete response before neoadjuvant chemotherapy may facilitate more tailored therapeutic planning for breast cancer patients. This work proposes a deep-learning model for pretreatment data only, combining apparent diffusion coefficient maps, dynamic contrast-enhanced magnetic resonance imaging, and clinical variables. The study uses the public ACRIN 6698/I-SPY2 multicenter dataset. The architecture employs EfficientNet-B0 pretrained encoders for image feature extraction and late fusion with clinical information. Multiple clinical variables were evaluated, including age, race, histological type, HR/HER2 subtype, SBR grade, and maximum diameter. Only HR/HER2 subtype improved the average area under the receiver operating characteristic curve (AUC) and was retained in the final model. Using stratified five-fold cross-validation, standalone apparent diffusion coefficient maps achieved a mean AUC of 0.79, whereas dynamic contrast-enhanced magnetic resonance imaging achieved 0.74. Adding HR/HER2 subtype improved performance to 0.83 and 0.81, respectively. The final configuration, using both imaging modalities and HR/HER2 subtype, achieved an AUC of 0.86. These results support pretreatment multimodal learning for response prediction, although external validation is required before clinical use.

0.27